Getting Our Priorities Straight: The Relationship between Cost-Effectiveness Evidence and Burden of Disease

This online event is hosted by the Center for the Evaluation of Value and Risk in Health and features CGD Executive Vice President Amanda Glassman.

Join us for an important webinar focused on understanding how well available information on the cost-effectiveness of health interventions aligns with diseases and conditions that contribute the greatest global burden. We will explore where the gaps are greatest, how this varies by location, disease, and type of intervention, and discuss policy options for improving the alignment. Our discussion is particularly relevant now that health systems around the world are struggling with how best to respond to the COVID-19 pandemic, and what lessons can be learned for future outbreak prevention and control.

Featured speakers

• Peter Neumann, ScD, Director, Center for the Evaluation of Value and Risk in Health
• Dan Ollendorf, PhD, Director, Value Measurement & Global Health Initiatives, Center for the Evaluation of Value and Risk in Health
• Amanda Glassman, MSc, Executive Vice President of the Center for Global Development (CGD), CEO of CGD Europe, and Senior Fellow